Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors.

MLA

Wang, Zhenwei, et al. “Synthesis and Biological Evaluation of 4-(Pyridine-4-Oxy)-3-(Tetrahydro-2H-Pyran-4-Yl)-Pyrazole Derivatives as Novel, Potent of ALK5 Receptor Inhibitors.” Bioorganic & Medicinal Chemistry Letters, vol. 61, Apr. 2022, p. 128552. EBSCOhost, https://doi.org/10.1016/j.bmcl.2022.128552.

APA

Wang, Z., Zhang, Y., Wang, H., Wang, X., Yu, Z., & Zhao, L. (2022). Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors. Bioorganic & Medicinal Chemistry Letters, 61, 128552. https://doi.org/10.1016/j.bmcl.2022.128552

Chicago

Wang, Zhenwei, Yan Zhang, Hai Wang, Xiaowei Wang, Zhuangzhuang Yu, and Liwen Zhao. 2022. “Synthesis and Biological Evaluation of 4-(Pyridine-4-Oxy)-3-(Tetrahydro-2H-Pyran-4-Yl)-Pyrazole Derivatives as Novel, Potent of ALK5 Receptor Inhibitors.” Bioorganic & Medicinal Chemistry Letters 61 (April): 128552. doi:10.1016/j.bmcl.2022.128552.